首页 | 本学科首页   官方微博 | 高级检索  
     


A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)
Authors:Tetsuji Terazawa  Jin Matsuyama  Masahiro Goto  Ryohei Kawabata  Shunji Endo  Motohiro Imano  Shoichiro Fujita  Yusuke Akamaru  Hirokazu Taniguchi  Mitsutoshi Tatsumi  Sang-Woong Lee  Yoshitaka Kurisu  Hisato Kawakami  Yukinori Kurokawa  Toshio Shimokawa  Daisuke Sakai  Takeshi Kato  Kazumasa Fujitani  Taroh Satoh
Affiliation:1. Cancer Chemotherapy Center, Osaka Medical College, Takatsuki, Japan;2. Department of Surgery, Yao Municipal Hospital, Yao, Japan;3. Department of Surgery, Osaka Rosai Hospital, Sakai, Japan;4. Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan;5. Department of Surgery, Kindai University School of Medicine, Higashiosaka, Japan;6. Department of Surgery, Ikeda City Hospital, Ikeda, Japan;7. Department of Surgery, Minoh City Hospital, Minoh, Japan;8. Department of Surgery, Hoshigaoka Medical Center, Hirakata, Japan;9. Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Japan;10. Department of Pathology, Osaka Medical College, Takatsuki, Japan;11. Department of Medical Oncology, Kindai University School of Medicine, Higashiosaka, Japan;12. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan;13. Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan;14. Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan;15. Department of Gastroenterological Surgery, Osaka National Hospital, Osaka, Japan;16. Department of Surgery, Osaka Prefectural General Medical Center, Osaka, Japan
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号